Medpage Today on MSN1d
Most Clozapine Prescribers Satisfied With REMS Program
Among 196 doctors who prescribed clozapine, 64% said the positive aspects of the REMS certification process outweighed the ...
STAT14d
Pharmalittle: We’re reading about FDA OK for Vertex non-opioid pain drug, vaccine advisory committee, and more
Vertex Pharmaceuticals won approval from the U.S. Food and Drug Administration for a non-opioid pain drug, clearing the way ...
STAT8d
FDA clinical trial inclusivity guidelines will be back
Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...
Daily Mail on MSN14d
Revealed: Biden's deep state plot to sabotage RFK Jr's radical reforms
The Biden administration - in its final weeks - quietly stacked a key health committee in a move that could sabotage Robert F ...
Insurer Denies Access To Drugs Granted Accelerated Approval By FDA
Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...
JD Supra11d
Health Care Week in Review: OMB Issues and Rescinds Memo Freezing Federal Funds; Senate Finance and HELP Committees Hold HHS Nomination Hearings
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and ...
India’s apex drug adviser’s term expired in October. The govt didn’t know.
India's apex drug advisory body has been inactive since its term ended in October. This was brought to the health ministry's ...
India’s key drug advisory body ceases to exist, policy decisions on hold: Report
Reconstituting the DTAB is expected to take 2-3 months, as the board requires representation from the industry, as well as ...
The American Journal of Managed Care11d
OIG Report Seeks Better Oversight, Records for FDA’s Accelerated Approvals
Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has ...
Medscape25d
In the Pipeline: FDA Advisory Committee Reviews
Date and FDA Advisory Committee: May 6, 2004 joint meeting of the Nonprescription Drugs Advisory Committee and the Dermatologic & Ophthalmic Drugs Advisory Committee. Subject: Efficacy and ...
Stricter abortion laws may cause increased infant deaths − 2 maternal and child health researchers explain the data
Infant mortality in the U.S. has increased by 7% since the 2022 Dobbs v. Jackson U.S. Supreme Court decision overturned the ...
federalnewsnetwork.com15d
FDA’s accelerated approval pathway has a few potholes
The Health and Human Services Office of Inspector General has found that, in a few cases, FDA officials veered from the accelerated approval pathway.